We analyzed the patient-derived BC cells that were treated with tamoxifen and fulvestrant in Figures 1B and 1C and found that increased numbers of ALDH-positive cells were strongly correlated to increased expression of Notch target genes (HEY1 and HES1) (Figure 2A). Here, HEY1 is linked to breast cancer.